Globus Medical
- Country
- 🇧🇪Belgium
- Ownership
- -
- Employees
- 5K
- Market Cap
- -
- Introduction
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
Clinical Trials
15
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
REFLECT Scoliosis System Post Approval Study
- Conditions
- Idiopathic Scoliosis
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Globus Medical Inc
- Target Recruit Count
- 100
- Registration Number
- NCT06298812
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Prospective Robotic Global Research Study (PROGRESS)
- Conditions
- Lumbar Disc Disease
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Globus Medical Inc
- Target Recruit Count
- 200
- Registration Number
- NCT04257279
- Locations
- 🇺🇸
Southeastern Spine Institute, Mount Pleasant, South Carolina, United States
Amnios™ RT Outcomes Study
- Conditions
- Plantar Fasciitis
- First Posted Date
- 2019-09-12
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Globus Medical Inc
- Target Recruit Count
- 150
- Registration Number
- NCT04088383
- Locations
- 🇺🇸
Bio-X-Cell Research, San Antonio, Texas, United States
Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in Hemicraniectomies
- Conditions
- Hemicraniectomies
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2018-02-15
- Lead Sponsor
- Globus Medical Inc
- Registration Number
- NCT03371316
Patient Outcomes Using an Expandable Spacer
- Conditions
- Degenerative Disc Disease
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2021-08-23
- Lead Sponsor
- Globus Medical Inc
- Registration Number
- NCT03162666
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
- Prev
- 1
- 2
- 3
- Next
News
Spineway Secures GMED Approval for New ESP Prostheses Production Line, Doubles Manufacturing Capacity
Spineway's subsidiary Spine Innovations received GMED approval for a new production line dedicated to LP-ESP and CP-ESP intervertebral disc prostheses, marking a significant strategic milestone for the company.
Globus Medical Advances with New Robot Clearances and Product Launches in 2024
Globus Medical's ExcelsiusFlex robot received FDA 510(k) clearance, designed for stereotactic guidance in orthopedic joint or spine surgeries, marking a significant advancement in surgical technology.